| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020188762 |
| P356 | DOI | 10.1038/324473A0 |
| P698 | PubMed publication ID | 2946962 |
| P2093 | author name string | Steinhausen M | |
| Fleming JT | |||
| Marin-Grez M | |||
| P2860 | cites work | A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats | Q34281894 |
| Renal mechanism of action of rat atrial natriuretic factor | Q34533911 | ||
| Atriopeptins as cardiac hormones | Q39494859 | ||
| Atrial natriuretic factor causes specific relaxation of rat renal arcuate arteries | Q42145315 | ||
| A stop-flow study of intrarenal effects of atrial natriuretic factor | Q43479370 | ||
| Angiotensin II control of the renal microcirculation: effect of blockade by saralasin. | Q54425393 | ||
| An atrial peptide is a potent renal vasodilator substance | Q54475653 | ||
| Natriuretic effect of atrial extract on isolated perfused rat kidney. | Q54486324 | ||
| Hydronephrosis: a new method to visualize vas afferens, efferens, and glomerular network. | Q54495796 | ||
| Atrial natriuretic factor—a circulating hormone stimulated by volume loading | Q56983202 | ||
| Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide | Q59079885 | ||
| Dopamine receptor antagonists inhibit the natriuretic response to atrial natriuretic factor (ANF) | Q67290755 | ||
| A comparison of synthetic rat and human atrial natriuretic factor in conscious dogs | Q69988949 | ||
| Filtration pressure response to infusion of atrial natriuretic peptides | Q69991557 | ||
| The renal action of atrial natriuretic peptide during control of glomerular filtration | Q70010663 | ||
| Synthesis of atrial natriuretic peptides and studies on structural factors in tissue specificity | Q72824581 | ||
| Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs | Q72832237 | ||
| P433 | issue | 6096 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vasoconstriction | Q1067506 |
| vasodilation | Q14859627 | ||
| atrial natriuretic peptide | Q78185357 | ||
| P304 | page(s) | 473-476 | |
| P577 | publication date | 1986-12-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney | |
| P478 | volume | 324 |
| Q38172460 | 25th anniversary article: scalable multiscale patterned structures inspired by nature: the role of hierarchy |
| Q34496097 | A review of vasopeptidase inhibitors: a new modality in the treatment of hypertension and chronic heart failure |
| Q36627825 | Adaptation of renal function in heart failure. |
| Q53049446 | Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides. |
| Q48118844 | Altered vasopressin and natriuretic peptide levels in a rat model of spinal cord injury: implications for the development of polyuria. |
| Q37229313 | Analytical Issues with Natriuretic Peptides - has this been Overly Simplified? |
| Q24563522 | Another member of the cyclic nucleotide-gated channel family, expressed in testis, kidney, and heart |
| Q73877858 | Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat |
| Q39483022 | Atrial natriuretic factor. Possible implications in liver disease |
| Q42599434 | Atrial natriuretic factor: Its (patho)physiological significance in humans |
| Q37855607 | Atrial natriuretic factor: a protective role after acute renal ischemia? Is there room for it in kidney transplantation? |
| Q40387350 | Atrial natriuretic factor: implications for cardiac pacing and electrophysiology |
| Q37878590 | Atrial natriuretic peptide |
| Q45260774 | Atrial natriuretic peptide and the renal response to hypervolemia in nephrotic humans |
| Q50517230 | Atrial natriuretic peptide relaxes arterial basal tone induced by coarctation hypertension. |
| Q39485181 | Atrial natriuretic peptide: blood levels in human disease and their measurement |
| Q38327377 | Atrial natriuretic peptide: water and electrolyte homeostasis |
| Q68429330 | Atrial peptide natriuresis in the rat without genuine rise in filtration rate or wash-out of medullary electrolytes |
| Q48766762 | Autoradiographic discrimination of brain and atrial natriuretic peptide-binding sites in the rat kidney |
| Q48237778 | B-type natriuretic peptide in cardiovascular disease |
| Q92127154 | BNP as a Major Player in the Heart-Kidney Connection |
| Q43923288 | Brain natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in Type 1 diabetes mellitus |
| Q37740228 | Cardiac natriuretic peptides: from basic discovery to clinical practice |
| Q47916949 | Cardiomyokines from the heart |
| Q36382621 | Cardiovascular and metabolic effects of natriuretic peptides |
| Q26851289 | Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis |
| Q30382842 | Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome. |
| Q44807811 | Characterization and physiologic regulation of atrial natriuretic factor receptors in rabbit preglomerular renal microvessels |
| Q42466418 | Characterization of ANF receptors in cultured renal cortical vascular smooth muscle cells |
| Q48934412 | Corticosterone treatment results in enhanced release of peptidergic vesicles in astrocytes via cytoskeletal rearrangements |
| Q69304275 | Demonstration of atrial natriuretic peptide/cardiodilatin (ANP/CDD)-immunoreactivity in the salt gland of the Pekin duck |
| Q45153602 | Different mechanisms of polyuria and natriuresis associated with paroxysmal supraventricular tachycardia |
| Q40378674 | Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats |
| Q71754632 | Diversity and variability of smooth muscle phenotypes of renal arterioles as revealed by myosin isoform expression |
| Q67652041 | Dopaminergic effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats |
| Q57109154 | Early intervention in acute kidney injury |
| Q93524647 | Effect of exogenous ANP on initial renal function following 24-hour cold preservation |
| Q89449694 | Effect of low-dose atrial natriuretic peptide in critically ill patients with acute kidney injury: a retrospective, single-center study with propensity-score matching |
| Q44648994 | Effect of synthetic human atrial natriuretic peptide (102-126) in nephrotic syndrome |
| Q48650517 | Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery |
| Q45219084 | Effects of atrial natriuretic factor (ANF) on intraocular pressure and aqueous humor flow in the cynomolgus monkey |
| Q51576593 | Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. |
| Q35883578 | Effects of atrial natriuretic peptide on inter-organ crosstalk among the kidney, lung, and heart in a rat model of renal ischemia-reperfusion injury |
| Q53868801 | Effects of atrial natriuretic peptide on the extrasplenic microvasculature and lymphatics in the rat in vivo. |
| Q36077363 | Effects of continuous intermedin infusion on blood pressure and hemodynamic function in spontaneously hypertensive rats. |
| Q43573502 | Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects |
| Q51748582 | Effects of renal denervation and atrial natriuretic factor on tubular reabsorption in anaesthetized rats. |
| Q71979419 | Effects of urodilatin in the rat kidney: comparison with ANF and interaction with vasoactive substances |
| Q51608116 | Engineering the cardiovascular system. Blood pressure regulation. |
| Q64946770 | Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure. |
| Q44966230 | Enhanced urinary excretion of albumin and β2microglobulin in essential hypertension induced by atrial natriuretic peptide |
| Q81281204 | Evaluation of brain natriuretic peptide levels in hyperthyroidism and hypothyroidism |
| Q41175777 | Evidence for particulate guanylate cyclase in rat kidney after stimulation by atrial natriuretic factor. An ultracytochemical study |
| Q28073372 | From ARB to ARNI in Cardiovascular Control |
| Q68642480 | Glomerular blood flow |
| Q48131140 | Glucagon-like peptide-1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP-1 receptors |
| Q44306586 | Guanylyl cyclase mediates ANP-induced vasoconstriction of murine splenic vessels |
| Q42374001 | Heart failure epidemiology and novel treatments in Japan: facts and numbers |
| Q58971430 | How the heart rules the kidneys |
| Q34584701 | Hyponatremia in patients with neurologic disorders |
| Q67898464 | Immunohistochemical localization of atrial natriuretic peptide in the developing and adult mammalian kidney |
| Q35026151 | Importance of the renal medullary circulation in the control of sodium excretion and blood pressure |
| Q45400172 | Increased tubuloglomerular feed-back mediated suppression of glomerular filtration during acute volume expansion in rats |
| Q57396177 | Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial |
| Q44433225 | Inducing vasoconstriction by activating guanylyl cyclase |
| Q73020149 | Influence of atrial natriuretic factor on fluid efflux from the splenic circulation of the rat |
| Q37135306 | Interactions between atrial natriuretic factor and the autonomic nervous system. |
| Q24198115 | Interventions for protecting renal function in the perioperative period |
| Q54130869 | Intrarenal blood flow: microvascular anatomy and the regulation of medullary perfusion. |
| Q51360063 | Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure. |
| Q42480306 | Losartan reduces the vasorelaxant effect of atrial natriuretic peptide on basal tone in aorta |
| Q64237754 | Low-dose atrial natriuretic peptide for prevention or treatment of acute kidney injury: a systematic review and meta-analysis |
| Q35349065 | Mechanisms and amelioration of acute renal allograft failure in the cyclosporine era |
| Q36798343 | Mechanisms of diabetic hyperfiltration |
| Q47786370 | Mechanosensitive cation channels mediate afferent arteriolar myogenic constriction in the isolated rat kidney |
| Q47722037 | Metabolism and action of urodilatin infusion in healthy volunteers |
| Q38794203 | Molecular Physiology of Membrane Guanylyl Cyclase Receptors |
| Q41073119 | Molecular diversity of cyclic nucleotide-gated cation channels |
| Q26827702 | Natriuretic Peptides and Cardiometabolic Health |
| Q38288274 | Natriuretic hormones in brain function |
| Q73484879 | Natriuretic peptide receptors mediate different responses in rat renal microvessels |
| Q35169820 | Natriuretic peptides and acute renal failure |
| Q53578568 | Natriuretic peptides buffer renin-dependent hypertension. |
| Q36317204 | Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy |
| Q48541358 | Natriuretic peptides in the diagnosis of heart disease--first amongst equals? |
| Q34859064 | Nesiritide: a new drug for the treatment of decompensated heart failure |
| Q35626131 | Neurohormone activation. |
| Q38349798 | Novel RAAS agonists and antagonists: clinical applications and controversies. |
| Q38841682 | Novel biomarkers predicting cardiac function after acute myocardial infarction |
| Q58713633 | Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury |
| Q27027081 | Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure |
| Q54981618 | Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications. |
| Q61855390 | Plasma insulin during physiological and pathophysiological changes in atrial natriuretic factor |
| Q38747742 | Potential Expanded Indications for Neprilysin Inhibitors |
| Q24652602 | Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption |
| Q38022018 | Protected Graft Copolymer (PGC) in Imaging and Therapy: A Platform for the Delivery of Covalently and Non-Covalently Bound Drugs |
| Q31131772 | Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data |
| Q44599191 | Reactions of efferent venous segments in the ciliary process vasculature of albino rabbits |
| Q72541763 | Reduced renal hemodynamic response to atrial natriuretic peptide in elderly volunteers |
| Q93609063 | References |
| Q90057489 | Regulation of mitochondria function by natriuretic peptides |
| Q71845868 | Renal clearance of atrial natriuretic peptide during acute unilateral complete ureteral obstruction in the pig |
| Q43259019 | Renal effects of plant-derived oleanolic acid in streptozotocin-induced diabetic rats |
| Q41471283 | Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction. |
| Q87393334 | Section 3: Prevention and Treatment of AKI |
| Q46976370 | Selective endothelin B receptor blockade does not influence BNP-induced natriuresis in man. |
| Q55417815 | Serum Corin Level Is Associated With Subsequent Decline in Renal Function in Patients With Suspected Coronary Artery Disease. |
| Q35660792 | Significance of recently identified peptides in hypertension: endothelin, natriuretic peptides, adrenomedullin, leptin. |
| Q28585606 | Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure |
| Q35561813 | Structure, Regulation, and Function of Mammalian Membrane Guanylyl Cyclase Receptors, With a Focus on Guanylyl Cyclase-A |
| Q38346377 | Syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome: similarities and differences |
| Q37794574 | T-Type Ca Channel Blockade as a Determinant of Kidney Protection |
| Q35574016 | The Evolving Role of Nesiritide in Advanced or Decompensated Heart Failure |
| Q54311413 | The cause of a depressed glomerular filtration rate after an ischaemic insult: whole kidney and superficial nephron study in the dog. |
| Q37583865 | The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment |
| Q34171357 | The natriuretic peptides: physiology and role in left-ventricular dysfunction. |
| Q36192931 | The neurohormonal axis and biochemical markers of heart failure |
| Q34708039 | The regulation and measurement of plasma volume in heart failure |
| Q36835183 | The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides |
| Q67595249 | Urodilatin, not nitroprusside, combined with dopamine reverses ischemic acute renal failure |
| Q54196427 | Urodilatin: a new approach for the treatment of therapy-resistant acute renal failure after liver transplantation. |
| Q41909317 | Urodilatin: a new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients |
| Q39472273 | Vascular actions of atrial natriuretic peptide |
| Q36191278 | Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology |
| Q36815987 | Vasoactive peptides in cardiovascular (patho)physiology. |
| Q44472004 | Visualization of renal autoregulation in the split hydronephrotic kidney of rats |
| Q36690703 | Zaprinast accelerates recovery from established acute renal failure in the rat |
Search more.